Cover: Are the Wages of Sin $30 an Hour?

Are the Wages of Sin $30 an Hour?

Economic Aspects of Street Level Drug Dealing

Published 2004

by Robert J. MacCoun, Peter Reuter

The authors of this study interviewed 186 probationers in Washington, D.C., who acknowledged a recent history of drug dealing. Questions concerned their legitimate and illegitimate activities. Interviewees reported median net earnings of $721 per month from drug sales — $2,000 per month among the 37% who reported selling drugs on a daily basis. These figures compare with median monthly earnings of $800 from legitimate employment for the 75% who reported such earnings. Street-level drug dealing appears to be a complement to, rather than a substitute for, legitimate employment, and it appears to be less profitable than media reports would suggest.

Originally published in: Crime and Delinquency, v. 38, no. 4, October 1992, pp. 477-491.

This report is part of the RAND reprint series. The Reprint was a product of RAND from 1992 to 2011 that represented previously published journal articles, book chapters, and reports with the permission of the publisher. RAND reprints were formally reviewed in accordance with the publisher's editorial policy and compliant with RAND's rigorous quality assurance standards for quality and objectivity. For select current RAND journal articles, see External Publications.

This document and trademark(s) contained herein are protected by law. This representation of RAND intellectual property is provided for noncommercial use only. Unauthorized posting of this publication online is prohibited; linking directly to this product page is encouraged. Permission is required from RAND to reproduce, or reuse in another form, any of its research documents for commercial purposes. For information on reprint and reuse permissions, please visit www.rand.org/pubs/permissions.

RAND is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.